Funding news
Siren Biotechnology logo

Siren Biotechnology Secures $8.0

Recently funded · $8.0M Series aHospitals and Health CareUSView source

Get the full Siren Biotechnology company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Siren Biotechnology, a startup focused on reimagining cancer treatment, has closed an $8.0M Series A funding round. The company is developing a Universal AAV Immuno-Gene Therapy, a novel modality that merges two transformative therapeutic technologies: AAV gene therapy and cytokine immunotherapy. This combined approach aims to overcome key challenges in oncology, redefining how tumor cells are destroyed and how anti-tumor immunity is elicited.

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series a rounds

Companies that recently closed a Series a round.

#CompanyAmount
1
Sail logo

Sail

United States

$80.0M
2
Oxford Drug Design logo

Oxford Drug Design

United Kingdom

$5.0M
3
Netris logo

Netris

United States

$4.7M
4
Finnovate logo

Finnovate

India

$2.0M
5
Luxonis logo

Luxonis

United States

$14.0M